PMN-MDSCs from COVID-19 patients were able to inhibit the SARS-CoV-2-specific IFN-γ production by T cells (70) and expressed high levels of Arg-1, iNOS, and TGF-β messenger RNAs (mRNAs). The gene discussed is ARG1; the disease is COVID-19.